Clinical Trials
Prostate Cancer Treated with Prostatectomy or Radiation

This Information is provided to help patients identify clinical trials for educational purposes and not to recruit patients for any specific trials. Patients should consult with their personal doctor and the trial sponsors for additional information on trials of interest.

Study of the use of targeted therapy to improve quality of life for participants who have undergone radical prostatectomy

Number: NCT02499497
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Dana-Farber Cancer Institute|National Institute of Nursing Research (NINR)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Immunotherapy in stopping prostate cancer from coming back or relapsing

Number: NCT02772562
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Medical University of South Carolina|Bavarian Nordic, Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s)
A Study of Definitive Therapy with Chemotherapy, Androgen Deprivation, and Radiation Therapy to Treat Prostate Cancer After Prostatectomy

Number: NCT03043807
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sponsor Trial Information
Trial Location(s) and Contact(s)
Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

Number: NCT03070886
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): NRG Oncology|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Number: NCT03152786
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Wake Forest University Health Sciences|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Radiation Therapy in Treating Patients With Prostate Cancer Following Radical Prostate Surgery

Number: NCT03570827
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Mayo Clinic|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s)
Study of a DNA vaccine and Nivolumab in Patients With Non-Metastatic Recurrent Prostate Cancer

Number: NCT03600350
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Wisconsin, Madison|National Cancer Institute (NCI)|Bristol-Myers Squibb|Madison Vaccines Inc. (MVI)
Sponsor Trial Information
Trial Location(s) and Contact(s)




PHEN,Inc. © 2018 All rights reserved